The cut-off value of sortilin expression in CLL patients was determined at 7.2% (AUC: 0.98, sensitivity: 96.1%, specificity: 94.2%) (p≤0.0001) (Figure 2). This evidence concerns the gene SORT1 and B-cell chronic lymphocytic leukemia.